Report License
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Order Review
Acute Lymphoblastic Leukemia Therapeutics Market - By Therapy (Chemotherapy [Hype-CVAD, Linker Regimen], Targeted Therapy), Type (B-Cell, T-Cell), Age Group (Children, Adults), Gender (Male, Female), Treatment Providers, Global Forecast, 2024 – 2032
Report ID: GMI8368
Selected License: $8,350
Discount: $2,505
Order Total: $5,845
Need assistance?
Call us or write to us:
Phone : +1-302-846-7766
Toll-Free : +1-888-689-0688
Email: sales@gminsights.com
